CEO & Chairman of the Board of Dermira Inc (30-Year Financial, Insider Trades) Thomas G Wiggans (insider trades) bought 23,419 shares of DERM on 08/19/2019 at an average price of $8.54 a share. The total cost of this purchase was $199,998.
Dermira Inc is a biopharmaceutical company. It is engaged in identifying, developing and commercializing therapies to improve the lives of patients with dermatologic diseases. Dermira Inc has a market cap of $465.650 million; its shares were traded at around $8.56 with and P/S ratio of 8.19. Dermira Inc had annual average EBITDA growth of 18.20% over the past five years. GuruFocus has detected 3 severe warning signs with Dermira Inc. .
CEO Recent Trades:
- CEO & Chairman of the Board Thomas G Wiggans bought 23,419 shares of DERM stock on 08/19/2019 at the average price of $8.54. The price of the stock has increased by 0.23% since.
Directors and Officers Recent Trades:
- Chief Development Officer Luis C. Pena sold 23,419 shares of DERM stock on 08/19/2019 at the average price of $8.54. The price of the stock has increased by 0.23% since.
For the complete insider trading history of DERM, click here
.